Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
April C. S. Watt
Observed name:
April C. Watt
Institutions:
The University of Melbourne,
Peter MacCallum Cancer Centre
Observed institutions:
The University of Melbourne,
Peter MacCallum Cancer Centre,
Dana-Farber Cancer Institute,
Carnegie Mellon University
ORCID:
0000-0002-5145-5334
Observed ORCID:
0000-0002-5145-5334
OpenAlex ID:
A5085274564
CDK4/6 inhibition triggers anti-tumour immunity
2017
·
Shom Goel
, Molly J. DeCristo
, et al.
·
Nature
·
1,503
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors
2016
·
Shom Goel
, Qi Wang
, et al.
·
Cancer Cell
·
468
PDF
Cellular mechanisms underlying response and resistance to CDK4/6 inhibitors in the treatment of hormone receptor-positive breast cancer
2022
·
April C. Watt
, Shom Goel
·
Breast Cancer Research
·
143
PDF
INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2023
·
Catherine Dietrich
, Alec Trub
, et al.
·
Cancer Discovery
·
130
PDF
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity
2020
·
April C. Watt
, Paloma Cejas
, et al.
·
Nature Cancer
·
108
Cationic Nanogel-mediated Runx2 and Osterix siRNA Delivery Decreases Mineralization in MC3T3 Cells
2014
·
Arun R. Shrivats
, Eric Hsu
, et al.
·
Clinical Orthopaedics and Related Research
·
24
PDF
Cationic Nanostructured Polymers for siRNA Delivery in Murine Calvarial Pre-Osteoblasts
2013
·
Eric W. Hsu
, Shiguang Liu
, et al.
·
Journal of Biomedical Nanotechnology
·
19
Data from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024
·
Catherine Dietrich
, Alec Trub
, et al.
·
3
Rb-driven transcription limits its tumour-suppressive effects in breast cancer
2026
·
April C. Watt
, Antonio Ahn
, et al.
·
Nature
·
2
Correction: INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2025
·
Catherine Dietrich
, Alec Trub
, et al.
·
Cancer Discovery
·
2
PDF
Supplementary Synthetic Methods from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024
·
Catherine Dietrich
, Alec Trub
, et al.
·
1
Benchmarking normalisation methods for differential binding analysis in CUT&RUN
2026
·
Krutika Ambani
, Antonio Ahn
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Supplementary Table 1 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2025
·
Catherine Dietrich
, Alec Trub
, et al.
Supplementary Table 2 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2025
·
Catherine Dietrich
, Alec Trub
, et al.
Supplementary Figures 1-14 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2025
·
Catherine Dietrich
, Alec Trub
, et al.
PDF
Supplementary Synthetic Methods from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2025
·
Catherine Dietrich
, Alec Trub
, et al.
PDF
Figure 6 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024
·
Catherine Dietrich
, Alec Trub
, et al.
Figure 3 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024
·
Catherine Dietrich
, Alec Trub
, et al.
Figure 1 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024
·
Catherine Dietrich
, Alec Trub
, et al.
Supplementary Table 2 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024
·
Catherine Dietrich
, Alec Trub
, et al.
Figure 6 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024
·
Catherine Dietrich
, Alec Trub
, et al.
Supplementary Figures 1-14 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024
·
Catherine Dietrich
, Alec Trub
, et al.
PDF
Figure 5 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024
·
Catherine Dietrich
, Alec Trub
, et al.
Figure 5 from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024
·
Catherine Dietrich
, Alec Trub
, et al.
Data from INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
2024
·
Catherine Dietrich
, Alec Trub
, et al.
Show more works
View as search
Works count:
38
Citation count:
2,401
H-index:
7
I10-index:
7
Year
Topic
Type
